These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30255759)

  • 1. Combined Ligand-Based and Structure-Based Virtual Screening Approach for Identification of New Dipeptidyl Peptidase 4 Inhibitors.
    Upadhyay J; Gajjar A; Suhagia BN
    Curr Drug Discov Technol; 2019; 16(4):426-436. PubMed ID: 30255759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
    Musoev A; Numonov S; You Z; Gao H
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-based pharmacophore detection, screening of potential gliptins and docking studies to get effective antidiabetic agents.
    Agrawal R; Jain P; Dikshit SN
    Comb Chem High Throughput Screen; 2012 Dec; 15(10):849-76. PubMed ID: 23140189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finding a Potential Dipeptidyl Peptidase-4 (DPP-4) Inhibitor for Type-2 Diabetes Treatment Based on Molecular Docking, Pharmacophore Generation, and Molecular Dynamics Simulation.
    Meduru H; Wang YT; Tsai JJ; Chen YC
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27304951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a Novel Scaffold for Inhibition of Dipeptidyl Peptidase-4.
    Mishra A; Cross M; Hofmann A; Coster MJ; Karim A; Sattar A
    J Comput Biol; 2019 Dec; 26(12):1470-1486. PubMed ID: 31390221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based virtual screening of dipeptidyl peptidase 4 inhibitors and their in vitro analysis.
    Rahman SU; Ali HS; Jafari B; Zaib S; Hameed A; Al-Kahraman YMSA; Langer P; Iqbal J
    Comput Biol Chem; 2021 Apr; 91():107326. PubMed ID: 32739275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of DPP-IV inhibitors with a novel scaffold by multistep in silico screening.
    Uchida T; Wakasugi M; Kitamura T; Yamamoto T; Asakura M; Fujiwara R; Itoh T; Fujii H; Hirono S
    J Mol Graph Model; 2018 Jan; 79():254-263. PubMed ID: 29274572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mining of potential dipeptidyl peptidase-IV inhibitors as anti-diabetic agents using integrated
    Sharma S; Srivastava S; Shrivastava A; Malik R; Almalki F; Saifullah K; Alam MM; Shaqiquzzaman M; Ali S; Akhter M
    J Biomol Struct Dyn; 2020 Nov; 38(18):5349-5361. PubMed ID: 31813365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophore- based virtual screening, 3D- QSAR, molecular docking approach for identification of potential dipeptidyl peptidase IV inhibitors.
    Shah BM; Modi P; Trivedi P
    J Biomol Struct Dyn; 2021 Apr; 39(6):2021-2043. PubMed ID: 32242496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel hydrazine derivatives as selective DPP-IV inhibitors: findings from virtual screening and validation through molecular dynamics simulations.
    Tanwar O; Deora GS; Tanwar L; Kumar G; Janardhan S; Alam M; Shaquiquzzaman ; Akhter M
    J Mol Model; 2014 Apr; 20(4):2118. PubMed ID: 24687332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, structure-activity relationship, and pharmacophore modeling studies of pyrazole-3-carbohydrazone derivatives as dipeptidyl peptidase IV inhibitors.
    Wu D; Jin F; Lu W; Zhu J; Li C; Wang W; Tang Y; Jiang H; Huang J; Liu G; Li J
    Chem Biol Drug Des; 2012 Jun; 79(6):897-906. PubMed ID: 22381062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of tight-binding competitive inhibitors of dipeptidyl peptidase IV.
    Pascual Alonso I; Valiente PA; Valdés-Tresanco ME; Arrebola Y; Almeida García F; Díaz L; García G; Guirola O; Pastor D; Bergado G; Sánchez B; Charli JL
    Int J Biol Macromol; 2022 Jan; 196():120-130. PubMed ID: 34920066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
    Patel BD; Bhadada SV; Ghate MD
    Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DPP-IV Inhibitory Phenanthridines: Ligand, Structure-Based Design and Synthesis.
    Khalaf RA; Masalha D; Sabbah D
    Curr Comput Aided Drug Des; 2020; 16(3):295-307. PubMed ID: 30526469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (part I): virtual screening and activity assays.
    Guasch L; Ojeda MJ; González-Abuín N; Sala E; Cereto-Massagué A; Mulero M; Valls C; Pinent M; Ardévol A; Garcia-Vallvé S; Pujadas G
    PLoS One; 2012; 7(9):e44971. PubMed ID: 22984596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Potential Dipeptidyl Peptidase (DPP)-IV Inhibitors among
    Yang Y; Shi CY; Xie J; Dai JH; He SL; Tian Y
    Molecules; 2020 Jan; 25(1):. PubMed ID: 31906524
    [No Abstract]   [Full Text] [Related]  

  • 17. In silico approaches to predict the potential of milk protein-derived peptides as dipeptidyl peptidase IV (DPP-IV) inhibitors.
    Nongonierma AB; Mooney C; Shields DC; FitzGerald RJ
    Peptides; 2014 Jul; 57():43-51. PubMed ID: 24793774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of diverse dipeptidyl peptidase IV inhibitors via structure-based virtual screening.
    Li C; Lu W; Lu C; Xiao W; Shen X; Huang J; Liu G; Tang Y
    J Mol Model; 2012 Sep; 18(9):4033-42. PubMed ID: 22460522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure based virtual screening of MDPI database: discovery of structurally diverse and novel DPP-IV inhibitors.
    Tanwar O; Tanwar L; Shaquiquzzaman M; Alam MM; Akhter M
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3447-51. PubMed ID: 24948564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New leads for DPP IV inhibition: structure-based pharmacophore mapping and virtual screening study.
    Almasri IM; Taha MO; Mohammad MK
    Arch Pharm Res; 2013 Nov; 36(11):1326-37. PubMed ID: 23918649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.